About Spermosens
Spermosens is a company based in Lund (Sweden) founded in 2018 by Kushagr Punyani. It operates as a HealthTech. Spermosens offers products and services including JUNO-CHECKED. Spermosens operates in a competitive market with competitors including Exseed Health, Sandstone Diagnostics, Human Biogenesis, Bonraybio and neoMimix, among others.
- Headquarter Lund, Sweden
- Founders Kushagr Punyani
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spermosens Ab
-
Annual Revenue
Not available
-
Net Profit
-$924.75 K (USD)16.37as on Dec 31, 2024
-
EBITDA
-$823.21 K (USD)15.3as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spermosens
Spermosens offers a comprehensive portfolio of products and services, including JUNO-CHECKED.
Diagnoses male-factor infertility for suitable IVF treatment selection.
Funding Insights of Spermosens
Detailed funding history for Spermosens
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spermosens
Investment portfolio details for Spermosens
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spermosens
Detailed financials for Spermosens
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spermosens Comparisons
Peer comparison for Spermosens
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spermosens
Spermosens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exseed Health, Sandstone Diagnostics, Human Biogenesis, Bonraybio and neoMimix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a home-based sperm test kit
|
|
| Locked | Locked | Locked |
Provides rapid tests for accurate sperm count diagnostics.
|
|
| Locked | Locked | Locked |
Provider of reproductive health services and solutions
|
|
| Locked | Locked | Locked |
Bonraybio is focused on developing reproductive health solutions.
|
|
| Locked | Locked | Locked |
A microfluidics device for sperm selection and sorting is developed.
|
Detailed competitors of Spermosens
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spermosens
Complete news archive for Spermosens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spermosens
Spermosens was founded in 2018.
Spermosens is headquartered in Lund, Sweden.
John Stephen Lempert is the current CEO of Spermosens.
Spermosens is engaged in the development of innovative medical devices for diagnosing male-factor infertility. The company operates in the healthcare sector, specifically targeting fertility diagnostics. Its flagship product, JUNO-CHECKED, is designed to assess the fertilization capacity of sperm, enabling clinicians to choose between standard IVF or ICSI treatments. Solutions provided by Spermosens aim to reduce the number of IVF cycles required for successful pregnancy, addressing the global challenge of infertility affecting millions of couples.
Spermosens's top competitors include Exseed Health, Swimcount and Human Biogenesis.
Spermosens offers JUNO-CHECKED.